Compare the Effect of INS Alone and Added LTRA in Treatment of SAR

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions

Allergic Rhinitis

Interventions

DRUG

budesonide

SAR patients received treatment of a combination of budesonide and montelukast tablet or only intranasal budesonide randomly for 14 days

Trial Locations (1)

Beijing Tongren Hospital, Beijing

All Listed Sponsors

lead

Beijing Tongren Hospital

OTHER

NCT04077892 - Compare the Effect of INS Alone and Added LTRA in Treatment of SAR | Biotech Hunter | Biotech Hunter